Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese (NCT06732245)
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of Oral NA-931, Alone or in Addition to Open Label Subcutaneous Tirzepatide , to Investigate the Efficacy and Safety in Overweight or Obese Men and Women
🩺 Plain-English Summary (8th-Grade Level)
A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women
Who can join: Review the eligibility criteria below.
Location: Biomed Research Unit #90067-102 — Los Angeles, California
Age range: 19 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- Biomed Research Unit #90067-102 — Los Angeles, California
- Biomed Research Unit # 92121-103 — San Diego, California
- Biomed Research Unit # 94104-101 — San Francisco, California
- Biomed Research Unit # 33012-104 — Hialeah, Florida
- Biomed Research Unit # 32256-105 — Jacksonville, Florida
- Biomed Research Unit # 33461-106 — Lake Worth, Florida
- Biomed Research Unit # 10021-107 — New York, New York
- Biomed Research Unit # 77479-108 — Sugar Land, Texas
- Biomed Research Unit-NSW-2100-109 — Brookvale, New South Wales
- Biomed Research Unit-NSW-2065-110 — Saint Leonards,, New South Wales
- , Australia, 4101 Biomed Research Unit-NSW-4101-111 — South Brisbane, Queensland
- Biomed Research Unit-VIC-3124-112 — Camberwell, Victoria
- , Victoria, Australia, 3084 Biomed Research Unit-VIC-3084-113 — Heidelberg West, Victoria
- Biomed Research Unit-NZ-2025-115 — Papatoetoe, Auckland
- Biomed Research Unit-NZ- 6242-117 — Newtown, Wellington Region
- Biomed Research Unit-NZ-1010-114 — Auckland,
- Hamilton, New Zealand, 3200 Biomed Research Unit-NZ-3200-116 — Hamilton,
📞 Contact the Study Coordinator
Phone: (800) 824-5135
Email: research@biomedind.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity and Overweight
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Scottsdale, Arizona
- Impact of Chia Seeds on Human Breast Milk Composition — Boston, Massachusetts
- Brain and Behavior Influences on Obesity Development From Infancy Through Childhood — Baltimore, Maryland
- FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing) — Chapel Hill, North Carolina
- Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors — Baltimore, Maryland
Explore by condition: All Obesity and Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.